This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Epiontis Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ulrich Hoffmueller: Innovator in Epigenetic Assessment
Introduction
Ulrich Hoffmueller is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biological sample analysis through his innovative patent. His work focuses on enhancing the understanding of cellular composition in biological samples, which has important implications for medical diagnostics.
Latest Patents
Ulrich Hoffmueller holds a patent for a "Method for identifying the quantitative cellular composition in a biological sample." This invention provides an epigenetic haemogram, also known as an epigenetic blood cell count, which identifies a comprehensive picture of cellular composition. The method utilizes a normalization standard that includes a nucleic acid molecule with specific marker-regions for each blood cell type and a control-region that is cell-unspecific. This innovative approach allows for accurate assessments of various biological samples, including blood and tissue samples.
Career Highlights
Ulrich Hoffmueller is associated with Epiontis GmbH, where he continues to develop and refine his innovative methods. His work at the company emphasizes the importance of epigenetic assessments in understanding cellular dynamics and improving diagnostic techniques.
Collaborations
Ulrich collaborates with Sven Olek, contributing to advancements in the field of epigenetics and cellular analysis. Their partnership enhances the research and development efforts at Epiontis GmbH.
Conclusion
Ulrich Hoffmueller's contributions to the field of epigenetic assessment through his innovative patent demonstrate his commitment to advancing medical diagnostics. His work continues to influence the understanding of cellular composition in biological samples, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
